158439-80-6 Usage
Appearance
White to off-white crystalline powder
Administration
Oral
Primary uses
Treatment of sickle cell anemia, certain types of cancer, and polycythemia vera
Mechanism (of action)
Slows or stops the growth of cancer cells and decreases the production of sickle-shaped red blood cells in individuals with sickle cell disease
Additional effects
Anti-inflammatory and immunosuppressive properties, making it potentially useful for treating conditions such as psoriasis and rheumatoid arthritis
Side effects (potential)
Bone marrow suppression and risk of developing secondary cancers
Description
A versatile medication with various potential therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 158439-80-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,8,4,3 and 9 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 158439-80:
(8*1)+(7*5)+(6*8)+(5*4)+(4*3)+(3*9)+(2*8)+(1*0)=166
166 % 10 = 6
So 158439-80-6 is a valid CAS Registry Number.
158439-80-6Relevant articles and documents
INDAZOLE DERIVATIVES WHICH INTERACT WITH THE G-PROTEIN COUPLED RECEPTOR FAMILY
-
Page/Page column 21-22, (2008/06/13)
Compounds of the general formula: (I) wherein Y, R and R’ are as described in the specification. Further included are pharmaceutical compositions comprising the compounds, processes for their preparation, as well as the use of the compounds for the prepar
